Amgen Splits AMG-706/Avastin Head-To-Head NSCLC Study Into Two Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
One trial will compare the multi-VEGF agent with Avastin in non-squamous non-small cell lung cancer and the second will study AMG-706’s effect in all non-small cell carcinoma patients.